Journal
SEMINARS IN NEPHROLOGY
Volume 31, Issue 1, Pages 47-58Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.semnephrol.2010.10.005
Keywords
Preeclampsia; autoimmune; angiotensin II; animal model; pregnancy
Categories
Funding
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076558] Funding Source: NIH RePORTER
- NHLBI NIH HHS [R01 HL076558-01A1, R01 HL076558-02, R01 HL076558-03, R01 HL076558-04, R01 HL076558] Funding Source: Medline
Ask authors/readers for more resources
Many reports indicate that there is an increase in almost all of the components of the renin-angiotensin system (RAS) during an uncomplicated pregnancy, but rerun activity, angiotensin II, and aldosterone decrease in preeclampsia (PE) for reasons that are unclear. PE is a life-threatening disorder of late pregnancy characterized by hypertension, proteinuria, increased soluble fms-like tyrosine kinase-1, as well as renal and placental morphologic abnormalities. Although a leading cause of maternal and perinatal morbidity and mortality, the pathogenic mechanisms of PE remain largely undefined. Immunologic mechanisms and aberrations of the RAS have been long considered contributors to the disorder. Bridging these two concepts, numerous studies report the presence of the angiotensin II type 1 receptor agonistic autoantibody (AT(1)-AA) found circulating in preeclamptic women. This autoantibody induces many key features of the disorder through AT(1) receptor signaling, and has been implicated in the pathogenesis of PE. Here we review the functions of the RAS during normal pregnancy and PE, and highlight the role of AT(1)-AA in both animal models and in the human disorder. Semin Nephrol 31:47-58 (C) 2011 Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available